Physician

Mylene Sy Go, M.D

According to 2025 Medicare claims, Mylene Go, M.D (NPI: 1992964696) practices hematology/oncology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is SOUTHERN ONCOLOGY HEMATOLOGY ASSOC (NPI: 1144211087; TIN: 222182145) and primary practice location at 08360-7059.

Go's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 554 traditional Medicare patients, billed 149,952 HCPCS/CPT codes, and received $2,024,627 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,797 prescription claims across 315 beneficiaries totaling $5,443,260 in drug costs, led by Darzalex Faspro (Daratumumab-Hyaluronidase-Fihj). 2020 DME data shows 23 claims. Open Payments data shows 65 records totaling $1,219. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $674,854 to $2,024,627. Similarly, Part D prescription costs have moved sharply higher in recent years, from $134,632 to $5,443,260. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	175	77,525	$674,854
2016	251	175,975	$1,273,913
2017	269	159,449	$1,199,618
2018	264	99,778	$1,063,169
2019	227	108,090	$945,549
2020	402	44,924	$527,808
2021	606	141,464	$1,726,052
2022	539	132,282	$1,832,313
2023	568	133,556	$1,689,549
2024	554	149,952	$2,024,627

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	245	$134,632
2016	97	476	$375,319
2017	106	643	$758,386
2018	102	727	$1,034,714
2019	96	735	$1,038,273
2020	135	604	$1,201,179
2021	222	1,131	$2,713,789
2022	243	1,242	$4,511,572
2023	258	1,386	$4,183,377
2024	315	1,797	$5,443,260

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	33	$6,565
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	23	$988
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	81	271	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	347	779	$108
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	155	221	$78
96372	Injection of drug or substance under skin or into muscle	107	320	$12
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	356	984	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	43	1,167	$733,364
Keytruda	Pembrolizumab	49	1,134	$606,521
Revlimid	Lenalidomide	27	756	$472,595
Ibrance	Palbociclib	23	644	$341,036
Imbruvica	Ibrutinib	16	448	$261,159

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	65	$1,219	Immunocore Limited
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mylene Sy Go, M.D?

Tedicare shows public-source Medicare data for Mylene Sy Go, M.D (NPI 1992964696), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mylene Sy Go, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mylene Sy Go, M.D?

Mylene Sy Go, M.D is linked to SOUTHERN ONCOLOGY HEMATOLOGY ASSOC (billing NPI 1144211087) in the available physician profile data.

Does Mylene Sy Go, M.D have Open Payments data?

Mylene Sy Go, M.D has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.